Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Disease Markers, enter your email address in the box below.

Disease Markers
Volume 2016, Article ID 3970284, 7 pages
http://dx.doi.org/10.1155/2016/3970284
Research Article

Serum NT-proBNP Levels Are Not Related to Vitamin D Status in Young Patients with Congenital Heart Defects

E. Passeri,1 R. Rigolini,2 E. Costa,2 C. Verdelli,3 C. Arcidiacono,4 M. Carminati,4 and S. Corbetta5

1Endocrinology Unit, IRCCS Policlinico San Donato, 20097 San Donato Milanese, Italy
2Laboratorio di Chimica Clinica, IRCCS Policlinico San Donato, 20097 San Donato Milanese, Italy
3Laboratory of Molecular Biology, IRCCS Policlinico San Donato, 20097 San Donato Milanese, Italy
4Pediatric Cardiosurgery, IRCCS Policlinico San Donato, 20097 San Donato Milanese, Italy
5Endocrinology Unit, Department of Biomedical Sciences for Health, University of Milan, IRCCS Policlinico San Donato, 20097 San Donato Milanese, Italy

Received 30 August 2015; Revised 1 November 2015; Accepted 4 November 2015

Academic Editor: Yi-Chia Huang

Copyright © 2016 E. Passeri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. I. E. Hoffman and S. Kaplan, “The incidence of congenital heart disease,” Journal of the American College of Cardiology, vol. 39, no. 12, pp. 1890–1900, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. I. E. Hoffman, S. Kaplan, and R. R. Liberthson, “Prevalence of congenital heart disease,” American Heart Journal, vol. 147, no. 3, pp. 425–439, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Dolk, M. Loane, and E. Garne, “The prevalence of congenital anomalies in Europe,” Advances in Experimental Medicine and Biology, vol. 686, pp. 349–364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D. van der Linde, E. E. M. Konings, M. A. Slager et al., “Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis,” Journal of the American College of Cardiology, vol. 58, no. 21, pp. 2241–2247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Khoshnood, N. Lelong, L. Houyel et al., “Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study,” Heart, vol. 98, no. 22, pp. 1667–1673, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Cantinotti, Y. Law, S. Vittorini et al., “The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update,” Heart Failure Reviews, vol. 19, no. 6, pp. 727–742, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Thygesen, J. Mair, C. Mueller et al., “Recommendations for the use of natriuretic peptides in acute cardiac care. A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care,” European Heart Journal, vol. 33, no. 16, pp. 2001–2006, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. National Clinical Guideline Centre (UK), “Chronic heart failure: national clinical guideline for diagnosis and management in primary and secondary care,” NICE Clinical Guidelines 108, 2010. View at Google Scholar
  9. J. Hilger, A. Friedel, R. Herr et al., “A systematic review of vitamin D status in populations worldwide,” British Journal of Nutrition, vol. 111, no. 1, pp. 23–45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Bansal, M. Bansal, P. Bajpai, and H. K. Garewal, “Hypocalcemic cardiomyopathy-different mechanisms in adult and pediatric cases,” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 8, pp. 2627–2632, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Högler, “Complications of vitamin D deficiency from the foetus to the infant: one cause, one prevention, but who's responsibility?” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 29, no. 3, pp. 385–398, 2015. View at Publisher · View at Google Scholar
  12. A. S. Kazmi and B. M. Wall, “Reversible congestive heart failure related to profound hypocalcemia secondary to hypoparathyroidism,” American Journal of the Medical Sciences, vol. 333, no. 4, pp. 226–229, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Xiang, T. Seki, M. D. Schuster et al., “Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia,” The Journal of Biological Chemistry, vol. 280, no. 47, pp. 39394–39402, 2005. View at Publisher · View at Google Scholar
  14. N. Bodyak, J. C. Ayus, S. Achinger et al., “Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 16810–16815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. K. A. Nibbelink, D. X. Tishoff, S. D. Hershey, A. Rahman, and R. U. Simpson, “1,25(OH)2-vitamin D3actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte,” Journal of Steroid Biochemistry and molecular Biology, vol. 103, no. 3–5, pp. 533–537, 2007. View at Publisher · View at Google Scholar
  16. D. X. Tishkoff, K. A. Nibbelink, K. H. Holmberg, L. Dandu, and R. U. Simpson, “Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility,” Endocrinology, vol. 149, no. 2, pp. 558–564, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Meredith and B. M. McManus, “Vitamin D in heart failure,” Journal of Cardiac Failure, vol. 19, no. 10, pp. 692–711, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Altay, A. Zorlu, S. Binici et al., “Relation of serum parathyroid hormone level to severity of heart failure,” The American Journal of Cardiology, vol. 109, no. 2, pp. 252–256, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. J. van Ballegooijen, I. Reinders, M. Visser, and I. A. Brouwer, “Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies,” American Heart Journal, vol. 165, no. 5, pp. 655.e5–664.e5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Gruson, S. A. Ahn, and M. F. Rousseau, “Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure,” Peptides, vol. 64, pp. 24–28, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Cacciari, S. Milani, A. Balsamo et al., “Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr),” Journal of Endocrinological Investigation, vol. 29, no. 7, pp. 581–593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al., “Evaluation, treatment, an prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, pp. 1911–1930, 2011. View at Google Scholar
  23. A. C. Ross, J. E. Manson, S. A. Abrams et al., “The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. 53–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. G. El-Hajj Fuleihan, R. Bouillon, B. Clarke et al., “Serum 25-hydroxyvitamin D levels: variability, knowledge gaps, and the concept of a desirable range,” Journal of Bone and Mineral Research, vol. 30, no. 7, pp. 1119–1133, 2015. View at Publisher · View at Google Scholar
  25. E. Hagström, P. Hellman, T. E. Larsson et al., “Plasma parathyroid hormone and the risk of cardiovascular mortality in the community,” Circulation, vol. 119, no. 21, pp. 2765–2771, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. L. L. Schierbeck, T. S. Jensen, U. Bang, G. Jensen, L. Køber, and J.-E. B. Jensen, “Parathyroid hormone and vitamin D-markers for cardiovascular and all cause mortality in heart failure,” European Journal of Heart Failure, vol. 13, no. 6, pp. 626–632, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. L. C. Y. Liu, A. A. Voors, D. J. van Veldhuisen et al., “Vitamin D status and outcomes in heart failure patients,” European Journal of Heart Failure, vol. 13, no. 6, pp. 619–625, 2011. View at Publisher · View at Google Scholar
  28. S. G. Wannamethee, P. Welsh, O. Papacosta, L. Lennon, P. H. Whincup, and N. Sattar, “Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease,” Circulation: Heart Failure, vol. 7, no. 5, pp. 732–739, 2014. View at Publisher · View at Google Scholar
  29. S. Pilz, W. März, B. Wellnitz et al., “Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 10, pp. 3927–3935, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Gruson, T. Lepoutre, S. A. Ahn, J. M. Ketelslegers, and M. F. Rousseau, “Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure,” Clinical Biochemistry, vol. 46, no. 4-5, pp. 391–394, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. B. Wetmore, R. Gadi, J. H. Lee et al., “Association of 25-hydroxyvitamin D deficiency with NT-pro BNP levels in patients with acute myocardial infarction: a cross-sectional analysis,” BMC Research Notes, vol. 4, article 542, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Seirafian, Y. Haghdarsaheli, M. Mortazavi, M. Hosseini, and F. Moeinzadeh, “The effect of oral vitamin D on serum level of N-terminal pro-B-type natriuretic peptide,” Advanced Biomedical Research, vol. 3, no. 1, p. 261, 2014. View at Publisher · View at Google Scholar
  33. C. M. Avitabile, M. B. Leonard, B. S. Zemel et al., “Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliation,” Heart, vol. 100, pp. 1702–1707, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. J. D. McNally, K. Menon, P. Chakraborty et al., “Impact of anesthesia and surgery for congenital heart disease on the vitamin D status of infants and children: a prospective longitudinal study,” Anesthesiology, vol. 119, no. 1, pp. 71–80, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. M. F. Holick, “Vitamin D deficiency,” The New England Journal of Medicine, vol. 357, no. 3, pp. 266–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. J. Rovner and K. O. O'Brien, “Hypovitaminosis D among healthy children in the United States: a review of the current evidence,” Archives of Pediatrics & Adolescent Medicine, vol. 162, no. 6, pp. 513–519, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Stagi, P. Pelosi, M. Strano et al., “Determinants of vitamin D levels in Italian children and adolescents: a longitudinal evaluation of cholecalciferol supplementation versus the improvement of factors influencing 25(OH)D status,” International Journal of Endocrinology, vol. 2014, Article ID 583039, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Smotkin-Tangorra, R. Purushothaman, A. Gupta, G. Nejati, H. Anhalt, and S. Ten, “Prevalence of vitamin D insufficiency in obese children and adolescents,” Journal of Pediatric Endocrinology and Metabolism, vol. 20, no. 7, pp. 817–823, 2007. View at Google Scholar · View at Scopus
  39. D. Gruson, B. Ferracin, S. A. Ahn et al., “1,25-dihydroxyvitamin D to PTH(1-84) ratios strongly predict cardiovascular death in heart failure,” PLoS ONE, vol. 10, no. 8, Article ID e0135427, 2015. View at Publisher · View at Google Scholar
  40. T. A. Outila, M. U. M. Kärkkäinen, and C. J. E. Lamberg-Allardt, “Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density,” The American Journal of Clinical Nutrition, vol. 74, no. 2, pp. 206–210, 2001. View at Google Scholar · View at Scopus
  41. L. Harkness and B. Cromer, “Low levels of 25-hydroxy vitamin D are associated with elevated parathyroid hormone in healthy adolescent females,” Osteoporosis International, vol. 16, no. 1, pp. 109–113, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Stagi, L. Cavalli, S. Ricci et al., “Parathyroid hormone levels in healthy children and adolescents,” Hormone Research in Paediatrics, vol. 84, no. 2, pp. 124–129, 2015. View at Publisher · View at Google Scholar
  43. M. R. Rutledge, V. Farah, A. A. Adeboye, M. R. Seawell, S. K. Bhattacharya, and K. T. Weber, “Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in Aldosteronism,” Cardiovascular Drugs and Therapy, vol. 27, no. 2, pp. 161–170, 2013. View at Publisher · View at Google Scholar · View at Scopus